GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00110721
Recruitment Status : Terminated (Study protocol amended to a new treatment regimen: study DAVFU-006.)
First Posted : May 13, 2005
Last Update Posted : March 6, 2012
Information provided by (Responsible Party):
Galectin Therapeutics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : February 2008